-
Product Insights
Ningxia-SPI Solar PV Park
Ningxia-SPI Solar PV Park is a solar PV project located in Ningxia, China. The project was developed by SPI Energy Co Ltd. The project came online in 2014. Empower your strategies with our Ningxia-SPI Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
SPI Anderson Biomass Power II
SPI Anderson Biomass Power II is a biopower project located in California, United States. The project is owned by Sierra Pacific Industries. The project came online in 2015. Empower your strategies with our SPI Anderson Biomass Power II report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Product Insights
SPI Solar Maryland Solar PV Park
SPI Solar Maryland Solar PV Park is a solar PV project located in Maryland, United States. The project is owned and being developed by SPI Solar Inc. The project is at the permitting stage. Empower your strategies with our SPI Solar Maryland Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
SPI Solar Illinois Solar PV Park
SPI Solar Illinois Solar PV Park is a solar PV project located in Illinois, United States. The project is owned and being developed by SPI Solar Inc. The project is at the permitting stage. Empower your strategies with our SPI Solar Illinois Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SPI-62 in Adrenocortical Hyperfunction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SPI-62 in Adrenocortical Hyperfunction report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SPI-62 in Adrenocortical Hyperfunction Drug Details: SPI-62 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SPI-62 in Cushing’s Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SPI-62 in Cushing's Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SPI-62 in Cushing's Syndrome Drug Details: SPI-62 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Prednisolone + SPI-62) in Polymyalgia Rheumatica (PMR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Prednisolone + SPI-62) in Polymyalgia Rheumatica (PMR) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Prednisolone + SPI-62) in Polymyalgia Rheumatica (PMR) Drug Details:...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tacrolimus in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tacrolimus in Pulmonary Arterial Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tacrolimus in Pulmonary Arterial Hypertension Drug Details: Tacrolimus (SPI-026) is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ebselen in Bipolar Disorder (Manic Depression)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ebselen in Bipolar Disorder (Manic Depression) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ebselen in Bipolar Disorder (Manic Depression) Drug Details: SPI-1005 (ebselen)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SPI-62 in Cushing’s Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SPI-62 in Cushing's Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SPI-62 in Cushing's Syndrome Drug Details:Concomitant therapy of SPI-62 and next generation corticosteroid...